Acute myelogenous leukemia: Current treatment and future directions
- 31 March 1992
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 92 (3) , 286-295
- https://doi.org/10.1016/0002-9343(92)90079-q
Abstract
No abstract availableKeywords
This publication has 94 references indexed in Scilit:
- Leukemia Following Chemotherapy for Ovarian CancerNew England Journal of Medicine, 1990
- The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory elementCell, 1989
- Clonal Chromosomal Abnormalities Showing Multiple-Cell-Lineage Involvement in Acute Myeloid LeukemiaNew England Journal of Medicine, 1988
- Allogeneic bone marrow transplantation versus intensification chemotherapy for acute myelogenous leukaemia in first remission: a prospective controlled trialBritish Journal of Haematology, 1988
- Benzene and LeukemiaNew England Journal of Medicine, 1987
- Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-HydroperoxycyclophosphamideNew England Journal of Medicine, 1986
- Marrow Transplantation from Related Donors Other Than HLA-Identical SiblingsNew England Journal of Medicine, 1985
- Leukemia and Preleukemia after Adjuvant Treatment of Gastrointestinal Cancer with Semustine (Methyl-CCNU)New England Journal of Medicine, 1983
- Increased Incidence of Acute Leukemia in Polycythemia Vera Associated with Chlorambucil TherapyNew England Journal of Medicine, 1981
- Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)New England Journal of Medicine, 1948